Vivekanand Bhor is an accomplished professional in the field of regulatory affairs and analytical research, currently serving as a Global RA at Serum Institute of India Pvt. Ltd. since March 2023. With a robust background in the pharmaceutical industry, Vivekanand has held various roles at Teva Pharmaceuticals from August 2016 to March 2023, progressing from Regulatory Affairs Associate I to Associate II, and Analytical Researcher, focused on Chemistry, Manufacturing, and Controls (CMC). Previous experience includes positions at Actavis Farmacêutica Ltda (Allergan Group and Watson Group), where Vivekanand contributed as Scientist II in formulation analytical R&D and other related capacities. Additional roles encompass a Junior Executive position at Watson Pharma Pvt Ltd and a Research Associate role at Sai Life Sciences Ltd. Vivekanand began the professional journey with a research project trainee role at MSD after earning a Master of Pharmacy in Medicinal and Pharmaceutical Chemistry from Sinhgad College of Pharmacy in 2010.